HomeCompareKBBTF vs PLD

KBBTF vs PLD: Dividend Comparison 2026

KBBTF yields 208.33% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KBBTF wins by $145.58M in total portfolio value
10 years
KBBTF
KBBTF
● Live price
208.33%
Share price
$0.96
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$151.48M
Annual income
$77,914,744.95
Full KBBTF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — KBBTF vs PLD

📍 KBBTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKBBTFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KBBTF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KBBTF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KBBTF
Annual income on $10K today (after 15% tax)
$17,708.33/yr
After 10yr DRIP, annual income (after tax)
$66,227,533.21/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, KBBTF beats the other by $62,189,416.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KBBTF + PLD for your $10,000?

KBBTF: 50%PLD: 50%
100% PLD50/50100% KBBTF
Portfolio after 10yr
$78.70M
Annual income
$41,332,735.06/yr
Blended yield
52.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

KBBTF
No analyst data
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KBBTF buys
0
PLD buys
0
No recent congressional trades found for KBBTF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKBBTFPLD
Forward yield208.33%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$151.48M$5.91M
Annual income after 10y$77,914,744.95$4,750,725.19
Total dividends collected$143.08M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: KBBTF vs PLD ($10,000, DRIP)

YearKBBTF PortfolioKBBTF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$31,533$20,833.33$11,241$540.96+$20.3KKBBTF
2$95,137$61,396.68$13,019$991.13+$82.1KKBBTF
3$274,915$173,118.00$15,801$1,870.97+$259.1KKBBTF
4$761,685$467,526.04$20,609$3,701.21+$741.1KKBBTF
5$2,025,599$1,210,595.57$29,919$7,867.97+$2.00MKBBTF
6$5,176,190$3,008,799.54$50,631$18,617.74+$5.13MKBBTF
7$12,724,177$7,185,654.07$105,528$51,352.20+$12.62MKBBTF
8$30,123,158$16,508,287.86$287,364$174,449.42+$29.84MKBBTF
9$68,756,679$36,524,900.02$1,081,760$774,280.77+$67.67MKBBTF
10$151,484,391$77,914,744.95$5,908,209$4,750,725.19+$145.58MKBBTF

KBBTF vs PLD: Complete Analysis 2026

KBBTFStock

Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices in the ophthalmic field worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also developing remote retinal monitoring device, a home-based and patient self-monitoring optical coherence tomography devices to treat wet age-related macular degeneration and diabetic macular edema, which brings retinal edema and reduction in visual acuity; and wearable device for myopia control. The company was founded in 2002 and is based in Tokyo, Japan.

Full KBBTF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this KBBTF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KBBTF vs SCHDKBBTF vs JEPIKBBTF vs OKBBTF vs KOKBBTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.